Contacts

MedinCell announces the initiation of coverage of its stock by TPICAP Midcap

January 5, 2023

TPICAP Midcap initiated coverage of MedinCell’s stock with a study entitled “Pipeline maturation: 1st launch likely in H1-23“, giving a recommendation to buy the stock with a price target of 15 euros per share.

Session en français

Rendez-vous le lundi 14 novembre à 18h00 (CET) pour une vidéoconférence dédiée aux récentes avancées des produits de notre portfeuille clinique

English session

On Monday 14, November at 6.00 pm (CET) participate in our videoconference dedicated to the latest news regarding our clinical and regulatory products

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.